Logo image of OKYO

OKYO PHARMA LTD (OKYO) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:OKYO - GG00BMFG5F62 - Common Stock

1.99 USD
-0.04 (-1.97%)
Last: 12/26/2025, 8:08:30 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
OKYO revenue by date.OKYO revenue by date.
N/AN/A
EBITDA
YoY % growth
OKYO ebitda by date.OKYO ebitda by date.
-20.16M-3.48M
82.74%
-1.21M
65.23%
-2.56M
-111.57%
-4.55M
-77.73%
-13.183M
-189.75%
-15.746M
-19.44%
-7.09M
54.97%
N/AN/A
EBIT
YoY % growth
OKYO ebit by date.OKYO ebit by date.
-20.16M-3.48M
82.74%
-1.21M
65.23%
-2.57M
-112.40%
-4.55M
-77.04%
-13.187M
-189.83%
-15.75M
-19.43%
-7.09M
54.98%
N/A
-38.83%
N/A
-103.11%
Operating Margin
OKYO operating margin by date.OKYO operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
OKYO eps by date.OKYO eps by date.
N/AN/AN/AN/AN/AN/AN/A
-4,543.98%
N/A
58.33%
N/A
-28.00%
N/A
-59.38%

All data in GBP

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.02
50.00%
-0.02
50.00%
-0.05-0.08
-60.00%
Revenue
Q2Q % growth
N/AN/AN/AN/A
EBITDA
Q2Q % growth
N/AN/AN/AN/A
EBIT
Q2Q % growth
-867K-867K
74.04%
-2.244M
-29.41%
-3.57M
4.80%

All data in GBP

Recent Earnings VS Estimates Surprises (GBP)
PeriodReportedEstimateDifferenceSurprise
OKYO Yearly EPS VS EstimatesOKYO Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 -0.1 -0.2 -0.3 -0.4
Recent Revenue VS Estimates Surprises (GBP)
PeriodReportedEstimateDifferenceSurprise
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A -12.28% -25.49%
RevenueN/A N/A N/A N/A